Which IVF stimulation is easier on patients? new study aims to find out
NCT ID NCT06175832
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two different ovarian stimulation methods used in IVF to see which one patients prefer and tolerate better. Sixty women undergoing either fertility preservation or preimplantation genetic testing will try both methods in a crossover design. The main goal is to measure treatment-related quality of life and satisfaction through questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Corifollitropin alfa (Elonva), recombinant FSH (Puregon), GnRH antagonist (Orgalutran), GnRH agonist (Gonapeptyl), progestin (Cerazette)
What this could lead to
If this trial succeeds, it could help identify which ovarian stimulation method is more comfortable and convenient for patients undergoing IVF or fertility preservation.
What could go wrong
This is a small, single-center phase 4 study with only 60 participants, so results may not apply to everyone. The focus is on patient satisfaction, not pregnancy or live birth rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for QUALITY OF LIFE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Ghent
RECRUITINGGhent, 9000, Belgium
Contact Email: •••••@•••••
Contact Email: •••••@•••••